Speakers
Cedric Hermans, Belgium
Haemophilia and gene therapy
Cedric Hermans currently heads the Division of Haematology, the Hemostasis and Thrombosis Unit as well as the Hemophilia Center of the Saint-Luc University Hospital in Brussels, Belgium. He was appointed Associate Professor at the Medical School of the Catholic University of Louvain in 2003, Full Professor in 2012 and Vice-Dean in 2015.
Professor Hermans has (co)-authored more than 85 original articles in international journals and is a member of several scientific societies and international advisory boards and collaborative research projects.
He was president of EAHAD and is currently member of the Board of Directors of the World Federation of Haemophilia and the Editor-in-Chief of the Haemophilia Journal.
His main research interests lie in the area of haemostasis and thrombosis, especially clinical studies on the treatment modalities and the wide spectrum of complications of haemophilia in both developed and developing countries, as well as new anticoagulants and the management of thrombosis.
https://www.researchgate.net/profile/Cedric-Hermans-2
https://dial.uclouvain.be/pr/boreal/en/search/site/cedric%20hermans
Paul Shiels, United Kingdom
How the exposome impacts the trajectory of age related health and disease
Paul is Professor of Cellular Gerontology at the Wolfson Wohl Translational Research Center at the University of Glasgow. He is a founder member of GARNER, the Glasgow Ageing Research Network. Paul has established a reputation in the biology of ageing with over 170 peer-reviewed publications in this arena.
Prof. Shiels has acted as an expert on the Biology of Ageing in a number of national policy advising consortia, including pSoBiD for the Chief Medical Officer of Scotland. His research has involved determining socio-economic, psychological, lifestyle and biological factors that are required for healthy ageing. He was the first to report on socioeconomic status and nutritional factors affecting epigenetic influences on health.
His current research portfolio comprises investigation and application of novel senotherapies and how the microbiome impacts on age related health.
Prof. Shiels has a proven track record in public dissemination of his research including the provision of expert commentary for the BBC and ABC TV networks and as a Panellist at the Edinburgh International Science Festival and the Edinburgh International Book Festival.
John-Bjarne Hansen, Norway
Venous thrombosis: From population studies to biological understanding
John-Bjarne Hansen is professor in haematology at the UiT – The Arctic University of Norway and senior consultant in haematology at the University hospital of North Norway. He is the leader of the Thrombosis Research Center (TREC), a translational research center with focus on venous thromboembolism (VTE) with the intention to identify novel risk factors and extend the understanding of molecular mechanisms with the long-term goal to lower the burden of VTE in the society. Professor Hansen is the chair of the Scientific and Standardization Committee (SSC) on Predictive and Diagnostic biomarkers in thrombotic disease in the International Society of Thrombosis and Haemostasis (ISTH).
Kathleen Freson, Belgium
Inherited platelet disorders – Genomics
Kathleen Freson is Professor at the University of Leuven in the department of Cardiovascular Sciences and head of the Centre for Molecular and Vascular Biology. She has a background in bioscience engineering and her research focussed on genetic and biology studies using platelets to unravel new bleeding disorders but she studied also other mainly neurological diseases where the platelet was used as a model cell for the disease. She is Chair of the ISTH Subcommittee ‘Genomics in Thrombosis and Hemostasis’ and is a member of the NIH-funded ClinGen working group for Thrombosis and Hemostasis.